AKT1 and Hodgkins lymphoma: Phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/PTEN/AKT/mTOR) signaling appears dysregulated in HL, as it is in many histologically different tumor types (Mossmann et al., 2018).